soul trial oral semaglutide cardiovascular outcomes 2024 2025 Reduces CV Events in T2DM β (NEJM, Mar 2025) Relevant for: cardiology, diabetology, nephrology, internal medicine π§ͺ T2DM + ASCVD/CKD π Oral semaglutide 14 mg vs placebo π ACC 2025: Oral Semaglutide Reduces
Description
These medications help people lose weight and manage blood sugar
GLP-1 weight-loss medications can make appetite feel smaller overnight. Thats powerful for fat loss but it can also make it harder to hit your protein needs
FDA-approved semaglutide products (Ozempic, Wegovy, Rybelsus) are commercially available
In a study published in the journal JAMA Internal Medicine, r
Kitchen & Pantry Essentials: Complete shopping lists with protein and fiber-rich foods to stock your home for success
